Tatva Chintan Pharma Share Price Today | Stock Price & Tatva Chintan Pharma Share Screener

Track the current stock price of Tatva Chintan Pharma with an interactive chart. Analyse TATVA share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Tatva Chintan Pharma stock quote in one place.

The quote of ₹1,799.00 sits between the 52-week low of ₹1,052.40 and the 52-week high of ₹1,806.40, and the latest session moved 3.20% from the previous close.

Screen Tatva Chintan Pharma company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for TATVA shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Chemicals sector and the Specialty Chemicals industry, and it trades under ISIN INE0GK401011.

Classification

Identifiers and Leadership

Screen TATVA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹1,004, up from ₹836 in 2025.

Latest statistics put total assets at ₹1,004 and shareholder funds at ₹782, with a leverage ratio of 0.10.

Screen Tatva Chintan Pharma income statement and profit fundamentals. Analyze TATVA quarterly results. Tatva Chintan Pharma reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹134 and net profit was ₹10, equal to earnings per unit of ₹4.41, at an operating margin of 21%.

In that period expenses were ₹106, interest cost ₹1 and tax ₹6. The next period listed, 2026-Jun, shows revenue of ₹170 and net profit of ₹16.

Screen TATVA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹32, and net cash flow was an outflow of ₹6.

Over the same period, investing activities used ₹116 and financing activities provided ₹79.

See Tatva Chintan Pharma shareholding pattern with promoter, FII, and DII holdings. Check Tatva Chintan Pharma promoter holding and ownership changes for TATVA on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 72.02%, foreign institutions 3.82%, domestic institutions 2.99% and the public 18.32%, spread across 66,842 shareholders.

The shareholder count was 66,842 in 2026-Mar, compared with 64,921 in 2026-Jun.

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Tatva Chintan Pharma. Tatva Chintan Pharma dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹2.00 per unit for 2026-March, a yield of 0.11%, compared with ₹1.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹2.00, ₹1.00 and ₹2.00 per unit.

See which indices include Tatva Chintan Pharma stock. Check TATVA index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 3 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE INDEX CARBON, BSE INDEX SMLCAP.

Get Tatva Chintan Pharma corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Tatva Chintan Pharma stock events that may affect TATVA share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Annual General Meeting dated September 25, 2026, with a record date of September 25, 2026.

It is followed by Dividend dated September 11, 2026 and Quarterly Result Announcement dated July 17, 2026.

Screen TATVA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Chemicals sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Screen TATVA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 2, 2026.

The next most recent announcements are dated October 1, 2026 and September 29, 2026.

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 5, 2026. This page covers 9 balance sheet periods, 15 income statement periods, 9 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.